Complete remission upon bortezomib-dexamethasone therapy in three heavily pretreated multiple myeloma patients relapsing after allogeneic stem cell transplantation

Ann Hematol. 2006 Aug;85(8):549-51. doi: 10.1007/s00277-006-0111-7. Epub 2006 Apr 13.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Anti-Inflammatory Agents / administration & dosage*
  • Boronic Acids / administration & dosage*
  • Bortezomib
  • Dexamethasone / administration & dosage*
  • Female
  • Graft Survival / drug effects*
  • Humans
  • Male
  • Multiple Myeloma / prevention & control*
  • Protease Inhibitors / administration & dosage*
  • Pyrazines / administration & dosage*
  • Recurrence
  • Remission Induction
  • Salvage Therapy
  • Stem Cell Transplantation*
  • Time Factors
  • Transplantation, Homologous

Substances

  • Anti-Inflammatory Agents
  • Boronic Acids
  • Protease Inhibitors
  • Pyrazines
  • Bortezomib
  • Dexamethasone